Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease.

Six Parkinsonian patients on long term levodopa therapy complained of short-lived deterioration of Parkinsonian symptoms immediately after levodopa intake. After withdrawal of the drug overnight, and following an oral challenge with levodopa/carbidopa (250/25) in all six cases, and with subcutaneous apomorphine (3 mg) in two, deterioration below base line levels of disability were observed which would not be explained by loss of sleep benefit. This occurred 10-20 minutes after levodopa challenge and lasted for 10-20 minutes. The latency and duration of this phenomenon were shorter with apomorphine but the characteristics were similar. This phenomenon may be due to an inhibitory effect of levodopa acting via presynaptic dopamine receptors.

[1]  A. Lees,et al.  Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes , 1990, The Lancet.

[2]  A. Grace,et al.  Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists. , 1979, Science.

[3]  W R Woodward,et al.  The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. , 1984, The New England journal of medicine.

[4]  A. J. Bradbury,et al.  A comparison of dopamine agonist action to inhibit locomotor activity and to induce stereotyped behaviour in the mouse. , 1984, European journal of pharmacology.

[5]  W R Woodward,et al.  Does an inhibitory action of levodopa contribute to motor fluctuations? , 1988, Neurology.

[6]  G. C. Cotzias,et al.  Protein intake and treatment of Parkinson's disease with levodopa. , 1975, The New England journal of medicine.

[7]  L. Paalzow,et al.  L-Dopa: how it may axacerbate parkinsonian symptoms , 1986 .

[8]  E. Tolosa,et al.  Apomorphine in Huntington's chorea: clinical observations and theoretical considerations. , 1974, Life sciences.

[9]  J. Costentin,et al.  Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats. , 1983, European journal of pharmacology.

[10]  C. Cianchetti,et al.  Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor. , 1978, Archives of neurology.

[11]  T. Davis,et al.  Acute effects of pulsatile levodopa administration on central dopamine pharmacodynamics , 1991, Neurology.